Tanshinone IIA improves cardiac function via regulating miR-499-5p dependent angiogenesis in myocardial ischemic mice

Microvascular Research - Tập 143 - Trang 104399 - 2022
Xian Wang1, Changwei Wu1
1Department of Cardiology, Huaian Medical District, General Hospital of Eastern Theater Command, No. 100 Jiankang East Road, Qingjiangpu District, Huaian City, Jiangsu Province, China

Tài liệu tham khảo

Al-Abd, 2017, Anti-angiogenic agents for the treatment of solid tumors: potential pathways, therapy and current strategies – a review, J. Adv. Res., 8, 591, 10.1016/j.jare.2017.06.006 Badimon, 2018, Microvasculature recovery by angiogenesis after myocardial infarction, Curr. Pharm. Des., 24, 2967, 10.2174/1381612824666180629162726 Baulina, 2022, Circulating miR-499a-5p is a potential biomarker of MYH7—associated hypertrophic cardiomyopathy, Int. J. Mol. Sci., 23, 3791, 10.3390/ijms23073791 Chen, 2019, Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma, J. Exp. Clin. Cancer Res., 38, 466, 10.1186/s13046-019-1436-0 Chen, 2020, Tanshinone IIA alleviates hypoxia/reoxygenation induced cardiomyocyte injury via lncRNA AK003290/miR-124-5p signaling, BMC Mol. Cell. Biol., 21, 20, 10.1186/s12860-020-00264-3 Du, 2018, Hypoxia-inducible factor 1 alpha (HIF-1alpha)/Vascular endothelial growth factor (VEGF) pathway participates in angiogenesis of myocardial infarction in muscone-treated mice: preliminary study, Med. Sci. Monit., 24, 8870, 10.12659/MSM.912051 Fu, 2019, Inhibition of miR-495 improves both vascular remodeling and angiogenesis in pulmonary hypertension, J. Vasc. Res., 56, 97, 10.1159/000500024 Gao, 2019, Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice, J. Mol. Cell. Cardiol., 137, 59, 10.1016/j.yjmcc.2019.09.012 Geng, 2020, Exosome derived from coronary serum of patients with myocardial infarction promotes angiogenesis through the miRNA-143/IGF-IR pathway, Int. J. Nanomedicine, 15, 2647, 10.2147/IJN.S242908 Goradel, 2018, Stem cell therapy: a new therapeutic option for cardiovascular diseases, J. Cell. Biochem., 119, 95, 10.1002/jcb.26169 Guo, 2018, Panax quinquefolium saponins attenuate myocardial dysfunction induced by chronic ischemia, Cell. Physiol. Biochem., 49, 1277, 10.1159/000493407 Hu, 2018, Knockdown of lncRNA MALAT1 attenuates acute myocardial infarction through miR-320-Pten axis, Biomed. Pharmacother., 106, 738, 10.1016/j.biopha.2018.06.122 Huang, 2020, Exosomes derived from miR-126-modified MSCs promote angiogenesis and neurogenesis and attenuate apoptosis after spinal cord injury in rats, Neuroscience, 424, 133, 10.1016/j.neuroscience.2019.10.043 Jeong, 2021, Pathological angiogenesis and inflammation in tissues, Arch. Pharm. Res., 44, 1, 10.1007/s12272-020-01287-2 Jung, 2017, Exosomes generated from iPSC-derivatives: new direction for stem cell therapy in human heart diseases, Circ. Res., 120, 407, 10.1161/CIRCRESAHA.116.309307 Lee, 2017, Tanshinone IIA inhibits angiogenesis in human endothelial progenitor cells in vitro and in vivo, Oncotarget, 8, 10.18632/oncotarget.22649 Li, 2018, Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics, Acta Pharmacol. Sin., 39, 802, 10.1038/aps.2017.193 Li, 2018, Tanshinone IIA and astragaloside IV promote the angiogenesis of mesenchymal stem cell-derived endothelial cell-like cells via upregulation of Cx37, Cx40 and Cx43, Exp. Ther. Med., 15, 1847 Li, 2021, Natural products: a promising therapeutics for targeting tumor angiogenesis, Front. Oncol., 11 Ma, 2018, MicroRNA-132, delivered by mesenchymal stem cell-derived exosomes, promote angiogenesis in myocardial infarction, Stem Cells Int., 2018, 10.1155/2018/3290372 Moussa, 2013, Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI), J. Am. Coll. Cardiol., 62, 1563, 10.1016/j.jacc.2013.08.720 Mouton, 2018, Myocardial infarction remodeling that progresses to heart failure: a signaling misunderstanding, Am. J. Physiol. Heart Circ. Physiol., 315, H71, 10.1152/ajpheart.00131.2018 Oka, 2014, Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure, Circ. Res., 114, 565, 10.1161/CIRCRESAHA.114.300507 Paneni, 2017, The aging cardiovascular system: understanding it at the cellular and clinical levels, J. Am. Coll. Cardiol., 69, 1952, 10.1016/j.jacc.2017.01.064 Reed, 2017, Acute myocardial infarction, Lancet, 389, 197, 10.1016/S0140-6736(16)30677-8 Saliminejad, 2019, An overview of microRNAs: biology, functions, therapeutics, and analysis methods, J. Cell. Physiol., 234, 5451, 10.1002/jcp.27486 Sui, 2017, Tanshinone IIA inhibits beta-catenin/VEGF-mediated angiogenesis by targeting TGF-beta1 in normoxic and HIF-1alpha in hypoxic microenvironments in human colorectal cancer, Cancer Lett., 403, 86, 10.1016/j.canlet.2017.05.013 Toraih, 2017, Structure and functional impact of seed region variant in MIR-499 gene family in bronchial asthma, Respir. Res., 18, 169, 10.1186/s12931-017-0648-0 Wang, 2020, MicroRNA-499 suppresses the growth of hepatocellular carcinoma by downregulating astrocyte elevated Gene-1, Technol. Cancer Res. Treat., 19 Xin, 2016, Circulating miR-499 as a potential biomarker for acute myocardial infarction, Ann. Transl. Med., 4, 10, 10.21037/atm.2016.03.40 Yehia, 2020, The clinical spectrum of PTEN mutations, Annu. Rev. Med., 71, 103, 10.1146/annurev-med-052218-125823 Zhou, 2018, miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges, Acta Pharmacol. Sin., 39, 1073, 10.1038/aps.2018.30